Means Investment Company’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-260
Closed -$288K 219
2021
Q3
$288K Hold
260
0.06% 151
2021
Q2
$383K Buy
+260
New +$361K 0.08% 138
2021
Q1
Sell
-95
Closed -$301K 193
2020
Q4
$301K Buy
+95
New +$151K 0.07% 145

Other funds holding LABU

Means Investment Company's LABU Position: Q4 2021 in Review

Means Investment Company sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2021, closing a stake of 260 shares — an estimated $288K sold.

Means Investment Company first reported a position in LABU in Q4 2020 and held it in 3 quarters. The position peaked at $383K in Q2 2021. 33 funds tracked by Wall St. Rank hold LABU as of Q4 2021.

  • Means Investment Company reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2021 after selling out during the quarter.
  • Means Investment Company sold 260 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2021, an estimated $288K.
  • Means Investment Company first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2020 and held it in 3 quarters.
  • Means Investment Company's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $383K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2021.

Based on Means Investment Company's 13F filing for Q4 2021, filed 14 Feb 2022.